HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled hope for cancer patients fighting dangerous viruses
Disease control Recruiting nowThis study is testing an experimental inhaled drug, PUL-042, to see if it can reduce the severity of lung infections caused by common respiratory viruses in a very vulnerable group. The participants are adults with blood cancers or who have received a stem cell transplant, and wh…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New hope to keep leukemia at bay after transplant
Disease control Recruiting nowThis study is testing whether a drug called ivosidenib can help prevent a specific type of leukemia (AML with an IDH1 mutation) from coming back after a patient has received a stem cell transplant. About 75 participants will be randomly assigned to receive either the study drug o…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Feb 27, 2026 15:06 UTC